Clinical Trials Logo

Superimposed Preeclampsia clinical trials

View clinical trials related to Superimposed Preeclampsia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02754778 Completed - Preeclampsia Clinical Trials

Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome

RedCarRisk
Start date: April 2016
Phase: N/A
Study type: Interventional

Evaluation of practicability in survey and test procedures and of successful implementation of complex interventions - feasibility analysis based on a pilot study: Influence of conditional workout postpartum on arterial stiffness among women with status after preeclampsia, superimposed preeclampsia or HELLP-syndrome

NCT ID: NCT02213094 Completed - Hypertension Clinical Trials

Phase I Study of Nicotinamide for Early Onset Preeclampsia

Start date: January 1, 2014
Phase: Phase 1
Study type: Interventional

This is a Phase I study of vitamin B3-amide (nicotinamide) dietary supplementation in pregnant women with early onset preeclampsia. The investigators will enroll 10 pregnant women at 24-32 weeks' gestation with the diagnosis of preeclampsia. If the woman is anticipated to remain undelivered for 48 hours after diagnosis she will receive vitamin B3-amide, 500 mg/day given in the morning (n=5) or 1000 mg given in the morning (n=5), continuing until delivery or for 14 days, whichever occurs first. Maternal blood will be collected at baseline and twice a day on days 1, 3, and 7 of nicotinamide administration to measure nicotinamide metabolites, The objectives of this Phase I study are to to test safety of nicotinamide.